Prostate Cancer Reports


Volume 2 Number 9
 September 2014

Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Number 9, September 2014

CONTENTS


Detection, Prevention, Screening
Epidemiology and risk factors
Integrative medicine
Prognosis and outcome
Psychosocial aspects
Staging
Treatment


DETECTION, PREVENTION, SCREENING



Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mćhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramón Y Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona U, Melia J, McKinley J, Mitra AV, Moynihan C, Rennert G, Suri M, Wilson P, Killick E; The IMPACT Collaborators, Moss S, Eeles RA.
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
Eur Urol. 2014 Jan 15. pii: S0302-2838(14)00004-9. doi: 10.1016/j.eururo.2014.01.003. [Epub ahead of print]
Abstract | Full text | Related citations


Kolostova K, Broul M, Schraml J, Cegan M, Matkowski R, Fiutowski M, Bobek V.
Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
Anticancer Res. 2014 Jul;34(7):3641-6.
Abstract | Related citations


Bratt O.
The Clinical Impact of Genetic Susceptibility to Prostate Cancer.
Eur Urol. 2014 Mar 25. pii: S0302-2838(14)00273-5. doi: 10.1016/j.eururo.2014.03.021. [Epub ahead of print]
Abstract | Full text | Related citations

EPIDEMIOLOGY AND RISK FACTORS



Ho TS, Howard LE, Vidal AC, Gerber L, Moreira DM, McKeever MG, Andriole GL Jr, Castro-Santamaria R, Freedland SJ.
Smoking and risk of low- and high-grade prostate cancer: Results from the REDUCE study.
Clin Cancer Res. 2014 Aug 19. pii: clincanres.2394.2013. [Epub ahead of print]
Abstract | Related citations

INTEGRATIVE MEDICINE



Elgass S, Cooper A, Chopra M.
Lycopene treatment of prostate cancer cell lines inhibits adhesion and migration properties of the cells.
Int J Med Sci. 2014 Jul 2;11(9):948-54. doi: 10.7150/ijms.9137. eCollection 2014.
Abstract | Full text | Related citations


Haque R, Van Den Eeden SK, Wallner LP, Richert-Boe K, Kallakury B, Wang R, Weinmann S.
Association of body mass index and prostate cancer mortality.
Obes Res Clin Pract. 2014 Jul-Aug;8(4):e374-81. doi: 10.1016/j.orcp.2013.06.002. Epub 2013 Aug 6.
Abstract | Related citations


Loprinzi PD, Richart SM.
White blood cell counts mediate the effects of physical activity on prostate-specific antigen levels.
Res Q Exerc Sport. 2014 Sep;85(3):409-13. doi: 10.1080/02701367.2014.930407.
Abstract | Related citations


Morote J, Celma A, Planas J, Placer J, de Torres I, Olivan M, Carles J, Reventós J, Doll A.
Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Int J Mol Sci. 2014 Aug 6;15(8):13615-23. doi: 10.3390/ijms150813615.
Abstract | Full text | Related citations


Patel D, Thevenet-Morrison K, van Wijngaarden E.
Omega-3 polyunsaturated fatty acid intake through fish consumption and prostate specific antigen level: Results from the 2003 to 2010 national health and examination survey.
Prostaglandins Leukot Essent Fatty Acids. 2014 Oct;91(4):155-60. doi: 10.1016/j.plefa.2014.07.008. Epub 2014 Jul 24.
Abstract | Related citations


Sak K.
Cytotoxicity of dietary flavonoids on different human cancer types.
Pharmacogn Rev. 2014 Jul;8(16):122-46. doi: 10.4103/0973-7847.134247.
Abstract | Full text | Related citations


Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA.
Urinary Melatonin Levels, Sleep Disruption, and Risk of Prostate Cancer in Elderly Men.
Eur Urol. 2014 Aug 5. pii: S0302-2838(14)00648-4. doi: 10.1016/j.eururo.2014.07.008. [Epub ahead of print]
Abstract | Related citations


Schwartz GG.
Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1447-9. doi: 10.1158/1055-9965.EPI-14-0520.
Abstract | Related citations


Wang L, Martins-Green M.
Pomegranate and Its Components as Alternative Treatment for Prostate Cancer.
Int J Mol Sci. 2014 Aug 25;15(9):14949-14966
Abstract | Full text | Related citations


Pelton K, Freeman MR, Solomon KR.
Cholesterol and prostate cancer.
Curr Opin Pharmacol. 2012 Dec;12(6):751-9. doi: 10.1016/j.coph.2012.07.006. Epub 2012 Jul 21.
Abstract | Full text | Related citations

PROGNOSIS AND OUTCOME



Brock G, Montorsi F, Büttner H, Henneges C, Mulhall J.
Reply from authors re: Arthur L. Burnett. Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy. Eur Urol 2014;65:597-8: although erection rehabilitation after prostatectomy remains indefinite, the most effective treatment, the earliest recovery, and the preservation of erectile function remain a definite goal.
Eur Urol. 2014 Mar;65(3):598-9. doi: 10.1016/j.eururo.2013.11.015. Epub 2013 Nov 19.
Abstract | Full text | Related citations


Burnett AL.
Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy.
Eur Urol. 2014 Mar;65(3):597-8. doi: 10.1016/j.eururo.2013.10.018. Epub 2013 Oct 28.
Abstract | Full text | Related citations


Dal Maso L, Guzzinati S, Buzzoni C, Capocaccia R, Serraino D, Caldarella A, Dei Tos AP, Falcini F, Autelitano M, Masanotti G, Ferretti S, Tisano F, Tirelli U, Crocetti E, De Angelis R; the AIRTUM Working group.
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types.
Ann Oncol. 2014 Aug 22. pii: mdu383. [Epub ahead of print]
Abstract | Full text | Related citations


Heidenreich A, Pfister D.
Pelvic Lymphadenectomy in Clinically Localised Prostate Cancer: Counting Lymph Nodes or Dissecting Primary Landing Zones of the Prostate?
Eur Urol. 2013 Jul 31. pii: S0302-2838(13)00750-1. doi: 10.1016/j.eururo.2013.07.035. [Epub ahead of print]
Abstract | Full text | Related citations


Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Sun M, Karakiewicz PI, Seitz C, Schramek P, Herman MP, Becker A, Loidl W, Pummer K, Nonis A, Lee RK, Lotan Y, Scherr DS, Seiler D, Chun FK, Graefen M, Tewari A, Gönen M, Montorsi F, Shariat SF, Briganti A.
Pathologic Nodal Staging Scores in Patients Treated with Radical Prostatectomy: A Postoperative Decision Tool.
Eur Urol. 2014 Sep 1. pii: S0302-2838(13)00656-8. doi: 10.1016/j.eururo.2013.06.041. [Epub 2013 Jul 2]
Abstract | Full text | Related citations


Prabhu V, Taksler GB, Sivarajan G, Laze J, Makarov DV, Lepor H.
Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms.
J Urol. 2014 Feb;191(2):412-7. doi: 10.1016/j.juro.2013.08.010. Epub 2013 Aug 13.
Abstract | Related citations


Richard A, Faeh D, Rohrmann S, Braun J, Tarnutzer S, Bopp M.
Italianity is associated with lower risk of prostate cancer mortality in Switzerland.
Cancer Causes Control. 2014 Aug 22. [Epub ahead of print]
Abstract | Related citations


Schiavina R, Borghesi M, Dababneh H, Pultrone CV, Chessa F, Concetti S, Gentile G, Vagnoni V, Romagnoli D, Della Mora L, Rizzi S, Martorana G, Brunocilla E.
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes.
Eur J Surg Oncol. 2014 Jul 18. pii: S0748-7983(14)00505-8. doi: 10.1016/j.ejso.2014.06.015. [Epub ahead of print]
Abstract | Related citations

PSYCHOSOCIAL ASPECTS



Albertsen PC.
Times, They Are a-Changing.
Eur Urol. 2014 Sep 1. pii: S0302-2838(13)01305-5. doi: 10.1016/j.eururo.2013.11.043. [Epub 2013 Dec 8]
Abstract | Full text | Related citations


Efficace F, Feuerstein M, Fayers P, Cafaro V, Eastham J, Pusic A, Blazeby J; EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Project).
Patient-reported Outcomes in Randomised Controlled Trials of Prostate Cancer: Methodological Quality and Impact on Clinical Decision Making.
Eur Urol. 2013 Oct 30. pii: S0302-2838(13)01090-7. doi: 10.1016/j.eururo.2013.10.017. [Epub ahead of print]
Abstract | Full text | Related citations


Lepor H.
Reply from Author re: Thorsten Schlomm, Meike Adam. Quality of Life After Radical Prostatectomy: Can We Give a “Lifetime Guarantee” to Our Patients? Eur Urol 2014;65:66–7: Long-term Quality of Life Outcomes Following Radical Prostatectomy: Encouraging Observations.
European Urology, Volume 65, Issue 1, January 2014, Page 68

Abstract | Full text
| Related citations


Prabhu V, Sivarajan G, Taksler GB, Laze J, Lepor H.
Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer.
Eur Urol. 2014 Jan;65(1):52-7. doi: 10.1016/j.eururo.2013.08.006. Epub 2013 Aug 9.
Abstract | Full text | Related citations


Schlomm T, Adam M.
Quality of life after radical prostatectomy: can we give a "lifetime guarantee" to our patients?
Eur Urol. 2014 Jan;65(1):66-7; discussion 68. doi: 10.1016/j.eururo.2013.09.009. Epub 2013 Sep 12.
Abstract | Full text | Related citations


Sivarajan G, Prabhu V, Taksler GB, Laze J, Lepor H.
Ten-year outcomes of sexual function after radical prostatectomy: results of a prospective longitudinal study.
Eur Urol. 2014 Jan;65(1):58-65. doi: 10.1016/j.eururo.2013.08.019. Epub 2013 Aug 26.
Abstract | Full text | Related citations

STAGING



Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Seitz C, Sun M, Karakiewicz PI, Schramek P, Herman MP, Becker A, Hansen J, Ehdaie B, Loidl W, Pummer K, Lee RK, Lotan Y, Scherr DS, Seiler D, Ahyai SA, Chun FK, Graefen M, Tewari A, Nonis A, Bachmann A, Montorsi F, Gönen M, Briganti A, Shariat SF.
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
Br J Cancer. 2014 Jul 15;111(2):213-9. doi: 10.1038/bjc.2014.311. Epub 2014 Jul 8.
Abstract | Related citations

TREATMENT



Radiotherapy after prostatectomy


Gandaglia G, Karakiewicz PI, Briganti A, Trudeau V, Trinh QD, Kim SP, Montorsi F, Nguyen PL, Abdollah F, Sun M.
Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria.
Int J Urol. 2014 Aug 21. doi: 10.1111/iju.12605. [Epub ahead of print]
Abstract | Related citations


Active surveillance

Ploussard G, Isbarn H, Briganti A, Sooriakumaran P, Surcel CI, Salomon L, Freschi M, Mirvald C, van der Poel HG, Jenkins A, Ost P, van Oort IM, Yossepowitch O, Giannarini G, van den Bergh RC; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.
Urol Oncol. 2014 Aug 14. pii: S1078-1439(14)00263-4. doi: 10.1016/j.urolonc.2014.07.007. [Epub ahead of print]
Abstract | Related citations


Wirth MP, Froehner M.
Predictive Significance of Confirmation Biopsies in Patients on Active Surveillance.
Eur Urol. 2014 Sep 1. pii: S0302-2838(13)00504-6. doi: 10.1016/j.eururo.2013.05.036. [Epub 2013 May 25]
Abstract | Full text | Related citations


Wong LM, Alibhai SM, Trottier G, Timilshina N, Van der Kwast T, Zlotta A, Lawrentschuk N, Kulkarni G, Hamilton R, Ferrara S, Margel D, Trachtenberg J, Jewett MA, Toi A, Evans A, Fleshner NE, Finelli A.
A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression.
Eur Urol. 2014 Sep 1. pii: S0302-2838(13)00423-5. doi: 10.1016/j.eururo.2013.04.038. Epub 2013 May 2.
Abstract | Full text | Related citations